Morbidity and mortality related to home parenteral nutrition in patients with gut failure

The clinical course of 39 patients on HPN for 5.5 years at The Cleveland Clinic Foundation were reviewed. Rehospitalization and mortality rates were relatively low in this group of patients who had significant disease processes. Rehospitalization and mortality were usually due to the primary underlying disease process rather than to the therapy. HPN is an efficacious, therapeutic modality that helps return patients with gut failure to a near normal life-style.